The largest database of trusted experimental protocols

Stata se statistical software release 17

Manufactured by StataCorp

Stata/SE Statistical Software: Release 17.0 is a data analysis and statistical software package. It provides tools for data management, statistical analysis, and visualization. The software is designed to handle a wide range of data types and can be used for a variety of statistical techniques, including regression analysis, time-series analysis, and multilevel modeling.

Automatically generated - may contain errors

Lab products found in correlation

2 protocols using stata se statistical software release 17

1

Medication Use in Aged Care Facilities

Check if the same lab product or an alternative is used in the 5 most similar protocols
The sample size of 19 RACFs was deemed to have sufficient statistical power. To estimate the statistical power of the helix, counterbalanced, three-strategy, and three-context area (medication type) trial design, we performed 1000 Monte Carlo simulations using Stata/SE Statistical Software: Release 17.0 (StataCorp. 2021). The sample size analysis was conducted at the RACF level based on the primary outcome (i.e. proportion of RACF-level Guideline concordant use of antipsychotics, benzodiazepines and antidepressants). The sample size was based on conducting analysis using a linear mixed model employing fixed, categorical factors for medication type and guideline implementation strategy and RACF as a random intercept. We assumed a minimum important effect size of an absolute change in the proportion of concordant medication category takers of 5% for the level 2 strategy relative to level 1 strategy and of 15% for the level 3 strategy relative to level 1 strategy. Given these assumptions, our sample size of 19 RACFs provides > 99% power to detect the absolute change in proportion of concordant medication category takers of 15% and 81% power to detect the absolute change in proportion of 5%.
+ Open protocol
+ Expand
2

Improving Medication Outcomes in Aged Care

Check if the same lab product or an alternative is used in the 5 most similar protocols
All primary analyses will be conducted using the intention-to-treat (ITT) principle. Level 3 intervention will be compared to level 1 and level 2 at the 6-month time point as a primary outcome (Table 4).
Per protocol analysis will also be undertaken with the per protocol set including all RACFs without a major protocol deviation. Major protocol deviations may include, but are not limited to, the following:

Loss of knowledge broker

Incomplete delivery of intervention (e.g. local action plans, QUM service)

We anticipate that the primary analysis will be conducted using a linear mixed model treating the RACF as a random effect, with the strategy level and medication contexts as fixed effects. Multiple imputation will be used to impute missing covariate values where necessary. Data will be analysed using Stata/SE Statistical Software: Release 17.0 (StataCorp. 2021).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!